Insider Selling: Tenet Healthcare (NYSE:THC) Director Sells $298,137.60 in Stock

Tenet Healthcare Corporation (NYSE:THCGet Free Report) Director Nadja West sold 1,152 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $258.80, for a total transaction of $298,137.60. Following the completion of the sale, the director owned 23,653 shares of the company’s stock, valued at approximately $6,121,396.40. The trade was a 4.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Tenet Healthcare Trading Up 0.7%

Shares of NYSE:THC opened at $265.28 on Friday. The company has a market capitalization of $21.36 billion, a P/E ratio of 10.23, a P/E/G ratio of 1.01 and a beta of 1.23. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The business’s 50 day simple moving average is $238.07 and its 200 day simple moving average is $211.23. Tenet Healthcare Corporation has a 1 year low of $157.58 and a 1 year high of $283.05.

Tenet Healthcare (NYSE:THCGet Free Report) last released its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company posted $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, research analysts anticipate that Tenet Healthcare Corporation will post 21.04 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

THC has been the subject of a number of recent analyst reports. Zacks Research raised shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. UBS Group boosted their price objective on shares of Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a research report on Monday, July 27th. TD Cowen raised their target price on Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a report on Monday, July 27th. Wells Fargo & Company boosted their price target on Tenet Healthcare from $231.00 to $281.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Finally, Mizuho set a $290.00 price objective on Tenet Healthcare in a research note on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $273.00.

Get Our Latest Report on THC

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Triumph Capital Management bought a new stake in Tenet Healthcare during the 3rd quarter worth approximately $25,000. Elyxium Wealth LLC bought a new stake in shares of Tenet Healthcare in the fourth quarter worth $29,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare during the 2nd quarter worth $35,000. Trust Co. of Vermont bought a new stake in shares of Tenet Healthcare in the 2nd quarter valued at about $37,000. Finally, Meeder Asset Management Inc. raised its position in shares of Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after acquiring an additional 114 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Further Reading

Insider Buying and Selling by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.